Canada invests in a new vaccine production plant in Toronto

The Government of Canada announced on Wednesday an investment to build a new flu vaccine factory in Toronto.

The· Federal government Invest up to $ 415 million to help pharmaceutical company Sanofi Pasteur Limited (Sanofi) build a new vaccine facility in Toronto. The facility primarily produces influenza vaccines and is capable of filling, finishing and testing vaccines.

The· Ontario Government Donate $ 55 million while Sanofi invests more than $ 455 million to enable a $ 925 million project. The company also plans to invest at least $ 79 million annually in Ontario R & D.

After careful consideration, Sanofi has selected Canada as the international production and distribution center for the Fluzone® high-dose tetravalent influenza vaccine, a high-dose seasonal influenza vaccine, according to François Philip Champagne, Minister of Innovation.Influenza vaccine Approved For people over the age of 65 by the National Advisory Committee on Immunization in Canada.

“Today’s announcement demonstrates Canada’s ability to attract foreign investment and develop facilities with Canadian-made solutions,” Champagne said in a statement on March 31.

“This once-in-a-generation investment demonstrates the government’s commitment to rebuild Canada’s domestic bio-manufacturing sector, focusing on both short-term strategic solutions and long-term visions.”

The facility is capable of producing sufficient vaccine doses for the entire Canadian population within approximately six months of the World Health Organization’s identification of a pandemic influenza strain, allowing Canada to prepare for future influenza outbreaks. Means.

Health Minister Patty Haidu, who attended during the presentation, said that building national capabilities in biotechnology could protect the health and safety of Canadians.

In addition to preparing for a pandemic, the facility is expected to create and retain more than 1,200 highly skilled jobs in Canada, according to Premier Doug Ford.

“This is an important investment to create quality jobs for 300 people and make the production of influenza and potentially other vaccines independent of others,” Ford said in a statement Wednesday. ..

Sanofi said the new Toronto site facility will be operational by 2026.